Process for the preparation of key intermediates for the synthesis of statins or pharmaceutically acceptable salts thereof

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 9085538
APP PUB NO 20140051854A1
SERIAL NO

13812458

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The invention relates to commercially viable process for the synthesis of key intermediates for the preparation of statins, in particular Rosuvastatin and Pitavastatin or respective pharmaceutically acceptable salts thereof. A new simple and short synthetic route for key intermediates is presented which benefits from the use of cheap and readily available starting materials, by which the conventionally most frequently used DIBAL-H as reducing agent can be avoided.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
LEK PHARMACEUTICALS D DVEROVSKOVA 57 LJUBLJANA 1526

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Casar, Zdenko Ljubljana, SI 17 26
Jukic, Marko Ljubljana, SI 8 201
Sterk, Damjan Ljubljana, SI 6 7

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
11.5 Year Payment $7400.00 $3700.00 $1850.00 Jan 21, 2027
Fee Large entity fee small entity fee micro entity fee
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00